Anbio Biotechnology NNNN
3.89 USD +0.30 (+8.36%)
At closeNov 6, 2026, 5:24 PM EST
3.75 -0.14 -3.60%
After hours · Nov 6, 5:24 PM ET
3.51 Day range 4.07
3.13 52-week range 41.11
- YTD
- -87.06%
- 1 year
- -76.22%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 8.65M | 8.19M | 6.71M | 23.54M | |
| 7.54M | 5.89M | 3.36M | 12.56M | |
| 5.77M | 2.00M | 1.96M | 10.20M | |
| 6.40M | 2.37M | 2.25M | 10.01M | |
| 0.147 | 0.056 | 0.105 | 100,112.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 7.77M | 11.76M | 9.69M | 7.10M | |
| 30.24M | 18.92M | 15.81M | 13.96M | |
| 87.84K | 1.73M | 993.06K | 1.41M | |
| 30.16M | 17.19M | 14.82M | 12.55M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -6.74M | 2.08M | 898.37K | 4.45M | |
| -4.20M | 337.10K | 1.73M | -1.53M | |
| 6.95M | -344.61K | -42.84K | 0 | |
| -3.99M | 2.07M | 2.59M | 2.92M |
